K Morimoto

Drastic neuronal loss in vivo by β-amyloid racemized at Ser26 residue: conversion of non-toxic [D-Ser26]β-amyloid 1–40 to toxic and proteinase-resistant fragments

Isamu Kaneko, K Morimoto, Tomoko Kubo · Neuroscience · 2001 · 93 citations

Neurodegenerative Diseases, Molecular Neuroscience, Ser26 Residue +11

Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons

K Morimoto, Kouji Yoshimi, T Tonohiro et al. · Neuroscience · 1998 · 76 citations

Neurodegenerative Diseases, Medicine, Neuropharmacology +7

Regional Increases in Brain‐Derived Neurotrophic Factor and Nerve Growth Factor mRNAs During Amygdaloid Kindling, But Not in Acidic and Basic Fibroblast Growth Factor mRNAs

Keiko Sato, Kenichi Kashihara, K Morimoto et al. · Epilepsia · 1996 · 61 citations

Delusional Disorder Molecular Genetic Evidence for Dopamine Psychosis

K Morimoto · Neuropsychopharmacology · 2002 · 57 citations · Full text

Psychiatry, Psychotic Disorder, Psychiatric Genetics +8

Mechanisms in the development of limbic status epilepticus and hippocampal neuron loss: an experimental study in a model of status epilepticus induced by kindling-like electrical stimulation of the deep prepyriform cortex in rats.

K. Inoue, K Morimoto, Kazunori Satō et al. · PubMed · 1992 · 15 citations

Synaptic Transmission, Neuromodulation Therapies, Neurotransmission +19